Search Results

Teva makes all efforts and invests many resources in order to provide all our customers with an equal, respectable, accessible and professional service.

We want to hear from you

Teva Privacy Notice for Pharmacovigilance, Medical Information and Product Complaints

We currently provide around 155 pharmaceutical products for human use to pharmaceutical companies, mainly in the form of tablets, capsules and injections. The R&D specialists we collaborate with at Teva, our parent company, maintain a strong development pipeline, enabling the timely availability of new products for our customers.

Discover Medis' vast generics portfolio accompanied with comprehensive regulatory support. Build a lasting partnership with Medis for out-licensing pharma dossiers.

What's Happening at Medis

Discover key 2024 trends shaping the dossier industry, from portfolio reassessments to ESG expectations and serialization. Learn how Medis is leading with innovative strategies to meet global demands.

Meet the Medis Scientific and Technical Affairs Team, a collective of experts offering specialized support in complex pharmaceutical matters, aiming to ensure successful dossier submissions, marketing authorization approvals, and continuous product supply. Discover their integral role in enhancing Medis' out-licensing capabilities through their expertise in regulatory affairs, serialization, and commercial support in the global pharmaceutical market.

Discover the convenience of Medis Now, the online customer portal for streamlined order tracking, quick order placement, and real-time data insights for the pharmaceutical industry. Save time and enhance your planning accuracy with Medis Now. Register today to transform your ordering experience!

Medis' Regulatory Affairs team is solid, constantly ready to tackle any new regulation or spontaneous challenge brought up due to the ever-expanding product portfolio and growing customer base. Here are 6 reasons why the team is always ready for action.

It's crucial to have the right supplier for your out-licensing generic drugs business. Working with a company you trust, who is efficient, and meets all your relevant needs is important if your business is to run smoothly and efficiently. But just how do you choose a supplier? What factors are important to consider?

Join Regina Thordardottir, a product launch coordinator at Medis, as she shares insights on successful launches, problem-solving, and the joy of hiking Iceland.

Join Regina Thordardottir, a product launch coordinator at Medis, as she shares insights on successful launches, problem-solving, and the joy of hiking Iceland.

Discover the unique challenges of out-licensing in the competitive Latin American market through the eyes of Simone Pasquini, the driving force behind Medis' business development in the region. Learn how her quarter-century of experience, multilingual skills, and strong relationships with customers help Medis grow its portfolio of high-quality generic medicines. See why Simone takes pride in her work, making medicine more affordable and accessible to patients in Brazil and beyond.

Olafur Ari Jonsson is Medis’ general counsel, supporting the company with the legal advice needed to navigate the complex world of pharma. Read about his work, what motivates him from day-to-day, and the cabin with the volcano view!

The Medis Customer Experience (CX) team are on the front line, talking to customers and dealing with all sorts of issues that crop up, on a daily basis. This role requires not just friendly and communicative personalities, but people who really care – about their clients and about their work. Lucky for us, we got to interview two members of this star team, Sigrun Saevarsdottir and Bojan Desnica. Here’s what they have to say on work, kids, and basketball!

Vilborg Huld Helgadottir is Europe Cluster Head at Medis, leading contract negotiation and product sales for the European markets. She talks to us about what drew her to the position, what matters most to Medis customers, and why it’s never Groundhog Day in the office.

Our experts are getting ready to connect at the CPhI Festival of Pharma in October.

We are delighted to share with you that Medis has been named as a finalist at the CPhI 2019 Awards, for “Excellence in Pharma: Regulatory Procedures and Compliance”, in relation to our exemplary work around Serialization.